Magnetic therapy headset shows improved cognitive function and mood in people with long COVID
A new study led by researchers from the Icahn School of Medicine at Mount Sinai and published in Brain Communications found that a transcranial low-amplitude magnetic field intervention delivered twice weekly into the brain through a noninvasive headset was associated with improvements in several measures of cognitive function and emotional well-being in people experiencing cognitive impairment…
A recent study conducted by researchers at the Icahn School of Medicine at Mount Sinai has found that a noninvasive magnetic therapy headset may improve cognitive function and mood in individuals with long COVID. The double-blind pilot trial involved 30 participants with cognitive impairment related to long COVID, who received either active magnetic therapy or a sham treatment.
Participants who received the active treatment showed improvements in working memory, verbal learning, processing speed, and emotional well-being compared to those in the sham group. These improvements persisted even four weeks after the treatment period ended. This is the first randomized controlled trial to evaluate the effectiveness of this magnetic therapy device, known as Microtesla Magnetic Therapy (MMT), in individuals with long COVID.
While the study shows promise, further research is needed to determine the long-term effects and whether the improvements translate into better everyday functioning. The researchers emphasize that the therapy is still in the investigational stage and not yet approved for treating long COVID.
Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
